All Stories

  1. In vitro Antioxidant and Antimicrobial Effects of Mimusops elengi (Linn.) Stem Bark Extract
  2. Hepatoprotective Effect of Callicarpa lanata (L.) against Antituberculosis Treatment-induced Acute Hepatotoxicity
  3. Therapeutic Potential of Indian Medicinal Herbs and Current Therapeutic Approach used to Mitigate the Symptoms of Chronic Fatigue Syndrome: A Review
  4. Stress Management Therapy through Adaptogens and Rasayanas in Ayurveda: A Comprehensive Review
  5. Pharmacokinetic Drug Interactions of Piperine: A Review of Pre-clinical and Clinical Studies
  6. GABAergic implications in anxiety and related disorders
  7. The Neuroanatomy, Etiopathogenesis, and Novel Therapeutic Targets in Depressive Disorders
  8. Gold Nanoparticle-based Biosensors for Point-of-Care Diagnostics: A Review of Sensing Nanoparticle Applications and Future Prospects
  9. Anti-oxidant and anti-inflammatory potential of different polymer-based mesalamine delayed-release granules in TNBS-induced ulcerative colitis in wistar rats
  10. Current Status of Alzheimer’s Disease and Pathological Mechanisms Investigating the Therapeutic Molecular Targets
  11. Nephroprotective effects of honokiol in a high-fat diet-streptozotocin rat model of diabetic nephropathy
  12. Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection
  13. Pharmacology of angiotensin in renovascular diseases
  14. Emerging Role of MicroRNA-30c in Neurological Disorders
  15. Quercetin Attenuates Nitroglycerin-Induced Migraine Headaches by Inhibiting Oxidative Stress and Inflammatory Mediators
  16. Neuroprotective Effects of Carbonic Anhydrase Inhibition and Cyclic Adenosine Monophosphate Activation in Mouse Model of Transient Global Cerebral Ischemia and Reperfusion
  17. Cardioprotective Activity of Cassia fistula L. Bark Extract in Isoproterenol-Induced Myocardial Infarction Rat Model
  18. Cardioprotection by Citrus grandis (L.) Peel Ethanolic Extract in Alloxan-Induced Cardiotoxicity in Diabetic Rats
  19. Neuroprotective Effects of Theobromine in permanent bilateral common carotid artery occlusion rat model of cerebral hypoperfusion
  20. Pharmacological Postconditioning by Protocatechuic Acid Attenuates Brain Injury in Ischemia–Reperfusion (I/R) Mice Model: Implications of Nuclear Factor Erythroid-2-Related Factor Pathway
  21. A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease
  22. Pharmacological Aspects of a Bioactive Compound Arbutin: A Comprehensive Review
  23. Mechanistic Insight into Diosmin-Induced Neuroprotection and Memory Improvement in Intracerebroventricular-Quinolinic Acid Rat Model: Resurrection of Mitochondrial Functions and Antioxidants
  24. Cucurbitacin B exerts neuroprotection in a murine Alzheimer’s disease model by modulating oxidative stress, inflammation, and neurotransmitter levels
  25. Neuroprotective Effects of Theobromine in Permanent Bilateral Common Carotid Artery Occlusion Rat Model of Cerebral Hypoperfusion
  26. Corrigendum: The Mechanisms of Cucurbitacin E as a Neuroprotective and Memory-Enhancing Agent in a Cerebral Hypoperfusion Rat Model: Attenuation of Oxidative Stress, Inflammation, and Excitotoxicity
  27. Caffeic Acid Prevents Vascular Oxidative Stress and Atherosclerosis against Atherosclerogenic Diet in Rats
  28. The Mechanisms of Cucurbitacin E as a Neuroprotective and Memory-Enhancing Agent in a Cerebral Hypoperfusion Rat Model: Attenuation of Oxidative Stress, Inflammation, and Excitotoxicity
  29. Arbutin attenuates monosodium L-glutamate induced neurotoxicity and cognitive dysfunction in rats
  30. Arbutin protects brain against middle cerebral artery occlusion-reperfusion (MCAo/R) injury
  31. Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s Disease
  32. Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice
  33. Neuroprotective effects of theobromine in transient global cerebral ischemia-reperfusion rat model
  34. Neuroprotective effects of arbutin against oxygen and glucose deprivation-induced oxidative stress and neuroinflammation in rat cortical neurons
  35. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington’s disease
  36. Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice
  37. The ameliorating approach of nanorobotics in the novel drug delivery systems: a mechanistic review
  38. Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
  39. Evaluation of Gamma Amino Butyric Acid (GABA) and Glibenclamide Combination Therapy in Streptozotocin Induced Diabetes
  40. Antimicrobial Activity of Juglans regia Root Bark Extracts
  41. Molecular Docking Approach to Identify Potential AntiCandidal Potential of Curcumin
  42. Fumaric acid protect the cadmium-induced hepatotoxicity in rats: owing to its antioxidant, anti-inflammatory action and aid in recast the liver function
  43. Memory improvement by modafinil at cost of metabolic hazards? A study to decipher the benefits and risks of modafinil in rats
  44. Amelioration of Dementia and Antioxidant Activity of Holarrhena antidysenterica Bark in Mice
  45. Amelioration of cognitive deficits by Spirulina platensis in L-methionine-induced rat model of vascular dementia
  46. Azelnidipine Ameliorates Dementia in Streptozotocin Treated Rats: Interplay between Oxidative Stress and Calcium
  47. Sucrose and saccharin differentially modulate depression and anxiety-like behavior in diabetic mice: exposures and withdrawal effects
  48. Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer’s disease: Involvement of PI3-kinase, eNOS and NFκB
  49. Ellagic acid prevents dementia through modulation of PI3-kinase-endothelial nitric oxide synthase signalling in streptozotocin-treated rats
  50. Caffeic acid phenethyl ester rescued streptozotocin-induced memory loss through PI3-kinase dependent pathway
  51. Effects of Chronic Lithium Chloride and L-Arginine Treatment on Prevention of Streptozotocin Induced Cognitive Deficits by Ellagic Acid
  52. Ellagic Acid Administration Negated the Development of Streptozotocin-Induced Memory Deficit in Rats
  53. Caffeic acid phenethyl ester (CAPE) prevents development of STZ-ICV induced dementia in rats
  54. Ellagic Acid Administration Reverses ColchicineInduced Dementia in Rats
  55. Pharmacological Evaluation of Cucumber for Cognition Enhancing Effect on Brain of Mice